Aesculytics is a New Zealand based consultancy providing regulatory support and epidemiological and computational research for medical device companies. It assists MedTech firms with Medsafe WAND notifications and international regulatory pathways for Class I and II devices, and uses predictive modelling, in-silico trials and computational evidence synthesis to support product validation. It does not provide clinical advice, diagnostics, or therapeutic treatments.
Target customer: MedTech and health-tech companies that need to bridge physiological data and regulatory approval in the New Zealand and international markets. The service is explicitly non-clinical, for regulatory and research purposes rather than direct patient care.
